Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Mar 01 01:21PM ET
2.77
Dollar change
-0.18
Percentage change
-6.26
%
Index- P/E- EPS (ttm)-0.37 Insider Own23.18% Shs Outstand6.25M Perf Week-13.98%
Market Cap17.31M Forward P/E- EPS next Y- Insider Trans0.00% Shs Float4.80M Perf Month-74.84%
Income-2.50M PEG- EPS next Q- Inst Own32.85% Short Float0.25% Perf Quarter-74.52%
Sales0.00M P/S- EPS this Y- Inst Trans8.20% Short Ratio0.62 Perf Half Y-74.26%
Book/sh-0.88 P/B- EPS next Y- ROA-2.65% Short Interest0.01M Perf Year-72.47%
Cash/sh1.35 P/C2.05 EPS next 5Y- ROE-3.03% 52W Range2.24 - 12.80 Perf YTD-74.82%
Dividend Est.- P/FCF- EPS past 5Y- ROI- 52W High-78.36% Beta-0.38
Dividend TTM- Quick Ratio1.76 Sales past 5Y0.00% Gross Margin- 52W Low23.66% ATR (14)1.16
Dividend Ex-Date- Current Ratio1.76 EPS Y/Y TTM-1090.42% Oper. Margin0.00% RSI (14)22.81 Volatility19.99% 37.10%
Employees3 Debt/Eq- Sales Y/Y TTM- Profit Margin- Recom- Target Price-
Option/ShortNo / Yes LT Debt/Eq- EPS Q/Q-1527.03% Payout- Rel Volume0.48 Prev Close2.95
Sales Surprise- EPS Surprise- Sales Q/Q- Earnings- Avg Volume19.54K Price2.77
SMA20-51.48% SMA50-68.81% SMA200-72.86% Trades Volume5,945 Change-6.26%
CERo Therapeutics Holdings, Inc. is a blank check company, formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The company was founded on June 8, 2021 and is headquartered in Oakland, CA.